Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of evolution of vaccination. We have Dr Srivastava and Dr Jaydeep Choudhury to lead the session.
It is well known to each one of us how the science of vaccine development has evolved starting from the invention of attenuated vaccines. We are also aware about the importance of vaccination for the children or neonates.
In this webinar, a more detailed discussion is provided on the development of 6-in-1 aP combination vaccine, its usage and its importance among the pediatric population.
The 6-in-1 aP combination vaccine is referred as DTaP/Hib/HepB/IPV, stands for 'Diphtheria, Tetanus, acellular Pertussis, Hib, Hepatitis B and Inactivated Polio Vaccine'. The advantage is one single vaccine can protect the child from the mentioned diseases and save the child from taking each of vaccines separately.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
2.
PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging
3.
finding fresh approaches to treating diffuse midline gliomas.
4.
June 20, 2023, Health Bulletin No. 12.
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Integrated Trends in Hematology for Modern Medicine
2.
Evidence-Based Insights in Oncology for Specialists
3.
Understanding the Rare Disease: Werner Syndrome Explained
4.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
5.
Advanced Practices in Hematology in Daily Practice
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation